Submandibular gland involvement in oral cavity squamous cell carcinoma: a retrospective multicenter study.
Head and neck cancer
Meta-analysis
Neck dissection
Oral cancer
Oral squamous cell carcinoma
Submandibular gland
Submandibular gland invasion
Systematic review
Journal
European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery
ISSN: 1434-4726
Titre abrégé: Eur Arch Otorhinolaryngol
Pays: Germany
ID NLM: 9002937
Informations de publication
Date de publication:
Sep 2023
Sep 2023
Historique:
received:
29
05
2022
accepted:
05
05
2023
medline:
31
7
2023
pubmed:
7
6
2023
entrez:
6
6
2023
Statut:
ppublish
Résumé
The submandibular gland (SMG) is routinely excised during neck dissection. Given the importance of the SMG in saliva production, it is important to understand its involvement rate by cancer tissue and the feasibility of its preservation. Retrospective data were collected from five academic centers in Europe. The study involved adult patients affected by primary oral cavity carcinoma (OCC) undergoing tumor excision and neck dissection. The main outcome analyzed was the SMG involvement rate. A systematic review and a meta-analysis were also conducted to provide an updated synthesis of the topic. A total of 642 patients were enrolled. The SMG involvement rate was 12/642 (1.9%; 95% CI 1.0-3.2) when considered per patient, and 12/852 (1.4%; 95% CI 0.6-2.1) when considered per gland. All the glands involved were ipsilateral to the tumor. Statistical analysis showed that predictive factors for gland invasion were: advanced pT status, advanced nodal involvement, presence of extracapsular spread and perivascular invasion. The involvement of level I lymph nodes was associated with gland invasion in 9 out of 12 cases. pN0 cases were correlated with a reduced risk of SMG involvement. The review of the literature and the meta-analysis confirmed the rare involvement of the SMG: on the 4458 patients and 5037 glands analyzed, the involvement rate was 1.8% (99% CI 1.1-2.7) and 1.6% (99% CI 1.0-2.4), respectively. The incidence of SMG involvement in primary OCC is rare. Therefore, exploring gland preservation as an option in selected cases would be reasonable. Future prospective studies are needed to investigate the oncological safety and the real impact on quality of life of SMG preservation.
Sections du résumé
BACKGROUND
BACKGROUND
The submandibular gland (SMG) is routinely excised during neck dissection. Given the importance of the SMG in saliva production, it is important to understand its involvement rate by cancer tissue and the feasibility of its preservation.
METHODS
METHODS
Retrospective data were collected from five academic centers in Europe. The study involved adult patients affected by primary oral cavity carcinoma (OCC) undergoing tumor excision and neck dissection. The main outcome analyzed was the SMG involvement rate. A systematic review and a meta-analysis were also conducted to provide an updated synthesis of the topic.
RESULTS
RESULTS
A total of 642 patients were enrolled. The SMG involvement rate was 12/642 (1.9%; 95% CI 1.0-3.2) when considered per patient, and 12/852 (1.4%; 95% CI 0.6-2.1) when considered per gland. All the glands involved were ipsilateral to the tumor. Statistical analysis showed that predictive factors for gland invasion were: advanced pT status, advanced nodal involvement, presence of extracapsular spread and perivascular invasion. The involvement of level I lymph nodes was associated with gland invasion in 9 out of 12 cases. pN0 cases were correlated with a reduced risk of SMG involvement. The review of the literature and the meta-analysis confirmed the rare involvement of the SMG: on the 4458 patients and 5037 glands analyzed, the involvement rate was 1.8% (99% CI 1.1-2.7) and 1.6% (99% CI 1.0-2.4), respectively.
CONCLUSIONS
CONCLUSIONS
The incidence of SMG involvement in primary OCC is rare. Therefore, exploring gland preservation as an option in selected cases would be reasonable. Future prospective studies are needed to investigate the oncological safety and the real impact on quality of life of SMG preservation.
Identifiants
pubmed: 37280380
doi: 10.1007/s00405-023-08007-8
pii: 10.1007/s00405-023-08007-8
pmc: PMC10382344
doi:
Types de publication
Systematic Review
Meta-Analysis
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
4205-4214Informations de copyright
© 2023. The Author(s).
Références
Kowalski LP, Bagietto R, Lara JRL, Santos RL, Silva JF Jr, Magrin J (2000) Prognostic significance of the distribution of neck node metastasis from oral carcinoma. Head Neck 22:207–214
doi: 10.1002/(SICI)1097-0347(200005)22:3<207::AID-HED1>3.0.CO;2-9
pubmed: 10748442
Crile G (1906) Excision of cancer of the head and neck with special reference to the plan of dissection base of one hundred and thirty-two operations. JAMA 47:1780–1786
doi: 10.1001/jama.1906.25210220006001a
Ding Z, Xiao T, Huang J, Yuan Y, Ye Q, Xuan M, Xie H, Wang X (2019) Elective neck dissection versus observation in squamous cell carcinoma of oral cavity with clinically N0 neck: a systematic review and meta-analysis of prospective studies. J Oral Maxillofac Surg 77(1):184–194. https://doi.org/10.1016/j.joms.2018.08.007 . (Epub 2018 Aug 22 PMID: 30218654)
doi: 10.1016/j.joms.2018.08.007
pubmed: 30218654
Shah JP, Candela FC, Poddar AK (1990) The patterns of cervical lymph node metastases from squamous carcinoma of the oral cavity. Cancer 66(1):109–113
doi: 10.1002/1097-0142(19900701)66:1<109::AID-CNCR2820660120>3.0.CO;2-A
pubmed: 2354399
Iocca O, Di Maio P, De Virgilio A, et al (2020) Lymph node yield and lymph node ratio in oral cavity and oropharyngeal carcinoma: Preliminary results from a prospective, multicenter, international cohort. Oral Oncol 107:104740. https://doi.org/10.1016/j.oraloncology.2020.104740 . (Epub 2020 May 4. PMID: 32380357)
doi: 10.1016/j.oraloncology.2020.104740
pubmed: 32380357
George A, Saseendran A, Joseph ST, Gopal KR (2021) Submandibular gland—the victim of neck dissection. Oral Oncol 123:105591. https://doi.org/10.1016/j.oraloncology.2021.105591 . (Epub 2021 Oct 30. PMID: 34744022)
doi: 10.1016/j.oraloncology.2021.105591
pubmed: 34744022
Cunning DM, Lipke N, Wax MK (1998) Significance of unilateral submandibular gland excision on salivary flow in noncancer patients. Laryngoscope 108(6):812–815. https://doi.org/10.1097/00005537-199806000-00007 . (PMID: 9628494)
doi: 10.1097/00005537-199806000-00007
pubmed: 9628494
Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71. https://doi.org/10.1136/bmj.n71
doi: 10.1136/bmj.n71
pubmed: 33782057
pmcid: 8005924
Agarwal G, Nagpure PS, Chavan SS (2016) Questionable necessity for removing submandibular gland in neck dissection in squamous cell carcinoma of oral cavity. Indian J Otolaryngol Head Neck Surg. 68(3):314–316. https://doi.org/10.1007/s12070-016-0966-4 . (Epub 2016 Feb 13. PMID: 27508132; PMCID: PMC4961650)
doi: 10.1007/s12070-016-0966-4
pubmed: 27508132
pmcid: 4961650
Ashfaq K, Ashfaq M, Ahmed A, Khan M, Azhar M (2014) Submandibular gland involvement in early stage oral cavity carcinomas: can the gland be left behind? J Coll Physicians Surg Pak 24(8):565–568 (PMID: 25149835)
pubmed: 25149835
Basaran B, Ulusan M, Orhan KS, Gunes S, Suoglu Y (2013) Is it necessary to remove submandibular glands in squamous cell carcinomas of the oral cavity? Acta Otorhinolaryngol Ital 33(2):88–92 (PMID: 23853397; PMCID: PMC3665381)
pubmed: 23853397
pmcid: 3665381
Byeon HK, Lim YC, Koo BS, Choi EC (2009) Metastasis to the submandibular gland in oral cavity squamous cell carcinomas: pathologic analysis. Acta Otolaryngol 129(1):96–100. https://doi.org/10.1080/00016480802032801 . (PMID: 18607927)
doi: 10.1080/00016480802032801
pubmed: 18607927
Cakir Cetin A, Dogan E, Ozay H, Kumus O, Erdag TK, Karabay N, Sarioglu S, Ikiz AO (2018) Submandibular gland invasion and feasibility of gland-sparing neck dissection in oral cavity carcinoma. J Laryngol Otol 132(5):446–451. https://doi.org/10.1017/S0022215118000592 . (Epub 2018 May 3 PMID: 29720283)
doi: 10.1017/S0022215118000592
pubmed: 29720283
Chen TC, Lo WC, Ko JY, Lou PJ, Yang TL, Wang CP (2009) Rare involvement of submandibular gland by oral squamous cell carcinoma. Head Neck 31(7):877–881. https://doi.org/10.1002/hed.21039 . (PMID: 19360744)
doi: 10.1002/hed.21039
pubmed: 19360744
Dhiwakar M, Ronen O, Malone J, Rao K, Bell S, Phillips R, Shevlin B, Robbins KT (2011) Feasibility of submandibular gland preservation in neck dissection: a prospective anatomic-pathologic study. Head Neck 33(5):603–609. https://doi.org/10.1002/hed.21499 . (Epub 2010 Aug 24 PMID: 20737484)
doi: 10.1002/hed.21499
pubmed: 20737484
Ebrahim AK, Loock JW, Afrogheh A, Hille J (2011) Is it oncologically safe to leave the ipsilateral submandibular gland during neck dissection for head and neck squamous cell carcinoma? J Laryngol Otol 125(8):837–840. https://doi.org/10.1017/S0022215111001095 . (Epub 2011 Jun 2 PMID: 21729447)
doi: 10.1017/S0022215111001095
pubmed: 21729447
Fives C, Feeley L, Sadadcharam M, O’Leary G, Sheahan P (2017) Incidence of intraglandular lymph nodes within submandibular gland, and involvement by floor of mouth cancer. Eur Arch Otorhinolaryngol 274(1):461–466. https://doi.org/10.1007/s00405-016-4205-0 . (Epub 2016 Jul 23 PMID: 27450469)
doi: 10.1007/s00405-016-4205-0
pubmed: 27450469
Jakhetiya A, Kaul P, Pandey A, Patel T, Kumar Meena J, Pal Singh M, Kumar GP (2021) Distribution and determinants of submandibular gland involvement in oral cavity squamous cell carcinoma. Oral Oncol 118:105316. https://doi.org/10.1016/j.oraloncology.2021.105316 . (105316. Epub 2021 Apr 30. PMID: 33940532)
doi: 10.1016/j.oraloncology.2021.105316
pubmed: 33940532
Javadi S, Khademi B, Mohamadianpanah M, Shishegar M, Babaei A (2021) Elective submandibular gland resection in patients with squamous cell carcinomas of the tongue. Iran J Otorhinolaryngol 33(114):23–29. https://doi.org/10.22038/ijorl.2020.44283.2463 . (PMID:33654687; PMCID:PMC7897437)
doi: 10.22038/ijorl.2020.44283.2463
pubmed: 33654687
pmcid: 7897437
Kruse A, Grätz KW (2009) Evaluation of metastases in the submandibular gland in head and neck malignancy. J Craniofac Surg 20(6):2024–2027. https://doi.org/10.1097/SCS.0b013e3181be87a3 . (PMID: 19881371)
doi: 10.1097/SCS.0b013e3181be87a3
pubmed: 19881371
Malgonde MS, Kumar M (2015) Practicability of submandibular gland in squamous cell carcinomas of oral cavity. Indian J Otolaryngol Head Neck Surg. 67(Suppl 1):138–140. https://doi.org/10.1007/s12070-014-0803-6 . (Epub 2014 Nov 22. PMID: 25621270; PMCID: PMC4298607)
doi: 10.1007/s12070-014-0803-6
pubmed: 25621270
Malik A, Joshi P, Mishra A, Garg A, Mair M, Chakrabarti S, Nair S, Nair D, Chaturvedi P (2016) Prospective study of the pattern of lymphatic metastasis in relation to the submandibular gland in patients with carcinoma of the oral cavity. Head Neck 38(11):1703–1707. https://doi.org/10.1002/hed.24508 . (Epub 2016 May 27 PMID: 27232643)
doi: 10.1002/hed.24508
pubmed: 27232643
Mazarei A, Khamushian P, Sadeghi Ivraghi M, Heidari F, Saeedi N, Golparvaran S, Yazdani N, Aghazadeh K (2021) Prevalence of submandibular gland involvement in neck dissection specimens of patients with oral cavity carcinoma. Am J Otolaryngol 43(2):103329. https://doi.org/10.1016/j.amjoto.2021.103329 . (Epub ahead of print. PMID: 34972007)
doi: 10.1016/j.amjoto.2021.103329
pubmed: 34972007
Naidu TK, Naidoo SK, Ramdial PK (2012) Oral cavity squamous cell carcinoma metastasis to the submandibular gland. J Laryngol Otol 126(3):279–284. https://doi.org/10.1017/S0022215111002660 . (Epub 2011 Oct 13 PMID: 22017858)
doi: 10.1017/S0022215111002660
pubmed: 22017858
Okoturo EM, Trivedi NP, Kekatpure V, Gangoli A, Shetkar GS, Mohan M, Kuriakose MA (2012) A retrospective evaluation of submandibular gland involvement in oral cavity cancers: a case for gland preservation. Int J Oral Maxillofac Surg 41(11):1383–1386. https://doi.org/10.1016/j.ijom.2012.07.016 . (Epub 2012 Sep 1 PMID: 22944141)
doi: 10.1016/j.ijom.2012.07.016
pubmed: 22944141
Panda NK, Patro SK, Bakshi J, Verma RK, Das A, Chatterjee D (2015) Metastasis to submandibular glands in oral cavity cancers: Can we preserve the gland safely? Auris Nasus Larynx 42(4):322–325. https://doi.org/10.1016/j.anl.2015.02.006 . (Epub 2015 Feb 25 PMID: 25724734)
doi: 10.1016/j.anl.2015.02.006
pubmed: 25724734
Pasha HA, Dhanani R, Ghaloo SK, Ghias K, Khan MJ (2021) Level I nodal positivity as a factor for involvement of the submandibular gland in oral cavity carcinoma: a case series report. Int Arch Otorhinolaryngol. 25(2):e279–e283. https://doi.org/10.1055/s-0040-1709117 . (PMID: 33968233; PMCID: PMC8096506)
doi: 10.1055/s-0040-1709117
pubmed: 33968233
Razfar A, Walvekar RR, Melkane A, Johnson JT, Myers EN (2009) Incidence and patterns of regional metastasis in early oral squamous cell cancers: feasibility of submandibular gland preservation. Head Neck 31(12):1619–1623. https://doi.org/10.1002/hed.21129 . (PMID: 19475546)
doi: 10.1002/hed.21129
pubmed: 19475546
Spiegel JH, Brys AK, Bhakti A, Singer MI (2004) Metastasis to the submandibular gland in head and neck carcinomas. Head Neck 26(12):1064–1068. https://doi.org/10.1002/hed.20109 . (PMID: 15459920)
doi: 10.1002/hed.20109
pubmed: 15459920
Yang S, Su JZ, Gao Y, Yu GY (2020) Clinicopathological study of involvement of the submandibular gland in oral squamous cell carcinoma. Br J Oral Maxillofac Surg 58(2):203–207. https://doi.org/10.1016/j.bjoms.2019.11.016 . (Epub 2019 Dec 19 PMID: 31864860)
doi: 10.1016/j.bjoms.2019.11.016
pubmed: 31864860
Yang S, Su JZ, Gao Y, Yu GY (2020) Involvement of the submandibular gland in oral squamous cell carcinoma patients with positive lymph nodes. J Stomatol Oral Maxillofac Surg 121(4):373–376. https://doi.org/10.1016/j.jormas.2019.12.004 . (Epub 2019 Dec 19 PMID: 31866411)
doi: 10.1016/j.jormas.2019.12.004
pubmed: 31866411
So WK, Chan RJ, Chan DN, Hughes BG, Chair SY, Choi KC, Chan CW (2012) Quality-of-life among head and neck cancer survivors at one year after treatment–a systematic review. Eur J Cancer 48(15):2391–2408. https://doi.org/10.1016/j.ejca.2012.04.005 . (Epub 2012 May 12 PMID: 22579456)
doi: 10.1016/j.ejca.2012.04.005
pubmed: 22579456
Gu B, Fang Q, Wu Y, Du W, Zhang X, Chen D (2020) Impact of submandibular gland preservation in neck management of early-stage buccal squamous cell carcinoma on locoregional control and disease-specific survival. BMC Cancer 20(1):1034. https://doi.org/10.1186/s12885-020-07534-5.PMID:33109130;PMCID:PMC7592590
doi: 10.1186/s12885-020-07534-5.PMID:33109130;PMCID:PMC7592590
pubmed: 33109130
pmcid: 7592590
Tagliabue M, Gandini S, Maffini F, Navach V, Bruschini R, Giugliano G, Lombardi F, Chiocca S, Rebecchi E, Sica E, Tommasino M, Calabrese L, Ansarin M (2019) The role of the T-N tract in advanced stage tongue cancer. Head Neck 41(8):2756–2767. https://doi.org/10.1002/hed.25761 . (PMID: 30942940)
doi: 10.1002/hed.25761
pubmed: 30942940
Alterio D, Augugliaro M, Tagliabue M, Bruschini R, Gandini S, Calabrese L, Belloni P, Preda L, Maffini FA, Marvaso G, Ferrari A, Volpe S, Zerella MA, Oneta O, Turturici I, Ombretta A, Francesca R, Mohssen A, Orecchia R, Jereczek-Fossa BA (2021) The T-N tract involvement as a new prognostic factor for PORT in locally advanced oral cavity tumors. Oral Dis. https://doi.org/10.1111/odi.13885 . (PMID: 33893695)
doi: 10.1111/odi.13885
pubmed: 33893695
Ferri A, Perlangeli G, Montalto N, Carrillo Lizarazo JL, Bianchi B, Ferrari S, Nicolai P, Sesenna E, Grammatica A (2020) Transoral resection with buccinator flap reconstruction vs. pull-through resection and free flap reconstruction for the management of T1/T2 cancer of the tongue and floor of the mouth. J Craniomaxillofac Surg 48(5):514–520. https://doi.org/10.1016/j.jcms.2020.02.010 . (PMID: 32171649)
doi: 10.1016/j.jcms.2020.02.010
pubmed: 32171649
Mendenhall WM, Mendenhall CM, Mendenhall NP (2014) Submandibular gland-sparing intensity-modulated radiotherapy. Am J Clin Oncol 37(5):514–516. https://doi.org/10.1097/COC.0b013e318261054e . (PMID: 22892434)
doi: 10.1097/COC.0b013e318261054e
pubmed: 22892434
Tam M, Riaz N, Kannarunimit D, Peña AP, Schupak KD, Gelblum DY, Wolden SL, Rao S, Lee NY (2015) Sparing bilateral neck level IB in oropharyngeal carcinoma and xerostomia outcomes. Am J Clin Oncol 38(4):343–347. https://doi.org/10.1097/COC.0000000000000064 . (PMID:26208401;PMCID:PMC5508539)
doi: 10.1097/COC.0000000000000064
pubmed: 26208401
pmcid: 5508539
Yu Y, Daly ME, Farwell DG, Luu Q, Gandour-Edwards R, Donald PJ, Chen AM (2015) Level IB nodal involvement in oropharyngeal carcinoma: implications for submandibular gland-sparing intensity-modulated radiotherapy. Laryngoscope 125(3):608–614. https://doi.org/10.1002/lary.24907 . (Epub 2014 Sep 12 PMID: 25215891)
doi: 10.1002/lary.24907
pubmed: 25215891
Varra V, Ross RB, Juloori A, Campbell S, Tom MC, Joshi NP, Woody NM, Ward MC, Xia P, Koyfman SA, Greskovich JF Jr (2019) Selectively sparing the submandibular gland when level Ib lymph nodes are included in the radiation target volume: an initial safety analysis of a novel planning objective. Oral Oncol 89:79–83. https://doi.org/10.1016/j.oraloncology.2018.12.021 . (Epub 2018 Dec 26 PMID: 30732963)
doi: 10.1016/j.oraloncology.2018.12.021
pubmed: 30732963